Developer docs
API playgroundTry for free, no card

Search company profiles

Syncora Holdings

Full company profile

uuid0039bi1

Namestring
Syncora Holdings
Legal namestring
Syncora
Websiteurl
syncora.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Syncora is a clinical study startup management platform delivered as a cloud-based SaaS solution, operated under parent company Digital Auxilius. The platform serves clinical research sites, pharmaceutical sponsors, and Contract Research Organizations (CROs), providing tools for site selection, activation, document management with version control, regulatory compliance, investigator tracking, and multi-site trial coordination. Core modules include Site Startup, Study Startup, File Manager, Lead Management, User Management, Site Tours, Event Scheduler, Investigator Management, and Reports/Dashboard Analytics, with regulatory features including 21 CFR Part 11-compliant electronic records and signatures, an Excel-to-CTMS data bridge, and PSV-SIV scheduling.

The platform is delivered as a web-based SaaS product accessible on desktop and mobile, with 24/7 support via email, live chat, and phone. Syncora monetizes through subscription pricing: a Teams tier at $499/month (for organizations billing up to $100K/month) and a custom Enterprise tier, with an annual commitment discount option. Distribution is primarily direct enterprise field sales anchored on a 'Book a Demo' CTA, supplemented by a free-trial self-serve channel for mid-market prospects. The company is privately held under Digital Auxilius, headquartered at 28260 Franklin Rd, Southfield, Michigan, and reports 100+ trials managed and 340+ sites onboarded. Leadership includes Founder and CEO Dr. Mazhar Jaffry, Chief Product Officer Khizar Jaffry, and Director Dr. Ashfaq Ahmed Mian.

Note on source material: the firmographics header describes Syncora Holdings as a Bermuda-domiciled, NYSE-listed (SCA) monoline financial guarantee insurer founded in 2006, whereas all other source blocks and the scraped website describe a US-based private clinical trial SaaS company. This analysis is grounded in the latter body of evidence, which is first-party and internally consistent.

Short descriptiontext

Syncora is a US-based clinical trial SaaS platform, operated under Digital Auxilius, that helps research sites, sponsors, and CROs manage study startup, site activation, document control, and regulatory compliance through subscription-priced workflow modules.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersHamilton, Bermuda
HQ citystring
Hamilton
HQ countrystring
Bermuda
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial software, site startup management, clinical research platform, regulatory compliance software, clinical study management
Industry2 codes
1Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
CodeHLAGACACPrimaryYes
2Clinical Trial Site Operations & Study Coordination
CodeHLAGACAEPrimaryNo
NAICS code2 codes
  • Software Publishers513210
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Clinical Trial Management Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS Subscription (Teams Plan)
TypeSubscription Recurring
Description

Monthly subscription at $499/month for Teams tier with access to Site Startup, Study Startup, Dashboard Analytics, and Lead Management features. Billed monthly with annual commitment.

syncora.com
2Enterprise Pricing
TypeSubscription Recurring
Description

Custom enterprise pricing for complex clinical research needs with scalable, secure, and intelligent solutions. Includes multi-site trial management, enterprise-level security, customizable workflows, and advanced analytics.

syncora.com
3Annual Subscription Discount
TypeSubscription Recurring
Description

$4800/year annual commitment option, offering savings compared to monthly billing

syncora.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details3 tiers
1Teams plan at $499/month for up to $100K billing/month with Site Startup, Study Startup, Dashboard Analytics, and Lead Management
ModelSubscriptionBilling cadenceMonthly
Notes

$499/month with annual commitment. Includes Site Startup, Study Startup, Dashboard Analytics, and Lead Management. For up to $100K billing/month.

syncora.com
2Enterprise plan with custom pricing for complex clinical research needs
ModelSubscriptionBilling cadenceAnnual
Notes

Custom quote tailored to needs. Includes centralized multi-site trial management, enterprise-level security, customizable workflows, and advanced analytics.

syncora.com
3Annual commitment option at $4800/year
ModelSubscriptionBilling cadenceAnnual
Notes

$4800/year annual commitment billed monthly. Alternative to monthly Teams plan.

syncora.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Syncora provides a cloud-based SaaS platform that streamlines clinical trial study startup activities, including site selection, site activation, document management, regulatory compliance, investigator coordination, and multi-stakeholder collaboration. The platform is sold to pharmaceutical sponsors, contract research organizations (CROs), and clinical research sites on subscription-based Teams and Enterprise pricing plans.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 62.5% reduction in average site activation time (from 120 days to 45 days in oncology trial case study)
+7 more records
Product overview1 text field

Syncora is a clinical study startup management platform delivered as a unified SaaS/hybrid solution. The core Syncora Platform serves as the central hub, integrated with modules for Site Startup, Lead Management, Study Startup, File Manager, User Management, Site Tours, Event Scheduler, and Investigator Management. Additional features include Networks for vendor coordination, Virtual Tour for site visualization, 21 CFR Part 11 compliance tools, and PSV-SIV Scheduler for visit coordination. The platform offers two pricing tiers: Teams ($499/month) and Enterprise (custom quote), supporting 100+ trials managed and 340+ sites onboarded.

Product and service1 record
1Syncora Platform
CategoryClinical Trial Management Software
Description

A cloud-based SaaS platform for clinical trial study startup management that streamlines site selection, site activation, document control, regulatory compliance, investigator coordination, lead management, and multi-stakeholder collaboration for pharmaceutical sponsors, CROs, and clinical research sites. Delivered as a subscription to pharmaceutical sponsors, CROs, and clinical research sites via Teams and Enterprise pricing plans.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeGTM or Marketing PartnerAnnounced on2025-09-01
Description

Syncora was a Performance Sponsor of the SCRS Global Site Solutions Summit 2025 held in Orlando, Florida. The summit brings together sites, sponsors, CROs, and solution providers to tackle clinical trial challenges. Syncora participated at Booth #901 to engage with industry professionals about their study startup management solutions.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

IQVIA's Orchestrated Clinical Trials suite includes site startup, CTMS, and site management offerings that compete for the same sponsor/CRO budget Syncora targets, with the added advantage of IQVIA's CRO services.

TypeBroad incumbent
Description

Veeva's Vault CTMS and Vault eTMF compete in clinical trial site and document management with a much broader life-sciences SaaS portfolio; the same enterprise buyers (sponsors, CROs) that Syncora targets are Veeva's core customers.

TypeEmerging player
Description

Castor offers a clinical trial data platform (EDC, ePRO, eConsent) with workflow tools aimed at sponsors, CROs, and sites — a comparable emerging SaaS peer competing for similar mid-market clinical research buyers.

TypeBroad incumbent
Description

Oracle's Clinical One platform unifies CTMS, EDC, and eTMF for sponsors and CROs and competes for the same clinical operations workflow footprint that Syncora targets, especially around site startup and study conduct.

TypeBroad incumbent
Description

Medidata's Rave platform spans CTMS, EDC, eCOA, and eTMF used by most large sponsors and CROs; it competes with Syncora for the clinical operations budget, particularly in site activation and study startup workflows.

TypeBroad incumbent
Description

Signant provides eCOA, eConsent, and clinical supply solutions that increasingly overlap with site startup and study conduct workflows targeted by Syncora, especially for sponsor-led studies.

7WCG
TypeBroad incumbent
Description

WCG provides IRB, IBC, technology, and consulting services for clinical research sites and sponsors — overlapping Syncora's regulatory, site start-up, and compliance value proposition through a different operating model.

TypeDirect peer
Description

Florence's eBinders/eISF and Trial Site Engagement platform manage site regulatory documents, file workflows, and study startup tasks — a closely comparable offering to Syncora's File Manager and Site Startup modules.

TypeDirect peer
Description

RealTime provides CTMS, eRegulatory, and site-management software widely used by independent research sites and site networks — directly competing with Syncora's site-side startup and compliance modules at similar price points.

TypeDirect peer
Description

Advarra offers IRB, IBC, and clinical technology solutions (including its own CTMS-adjacent workflow tooling) for sites, sponsors, and CROs — directly overlapping Syncora's regulatory and study-startup workflow value proposition.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment10 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature15 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Syncora Holdings

Clinical Trial Management Softwaresyncora.com

Syncora is a US-based clinical trial SaaS platform, operated under Digital Auxilius, that helps research sites, sponsors, and CROs manage study startup, site activation, document control, and regulatory compliance through subscription-priced workflow modules.

What Syncora Holdings does

Syncora is a clinical study startup management platform delivered as a cloud-based SaaS solution, operated under parent company Digital Auxilius. The platform serves clinical research sites, pharmaceutical sponsors, and Contract Research Organizations (CROs), providing tools for site selection, activation, document management with version control, regulatory compliance, investigator tracking, and multi-site trial coordination. Core modules include Site Startup, Study Startup, File Manager, Lead Management, User Management, Site Tours, Event Scheduler, Investigator Management, and Reports/Dashboard Analytics, with regulatory features including 21 CFR Part 11-compliant electronic records and signatures, an Excel-to-CTMS data bridge, and PSV-SIV scheduling.

The platform is delivered as a web-based SaaS product accessible on desktop and mobile, with 24/7 support via email, live chat, and phone. Syncora monetizes through subscription pricing: a Teams tier at $499/month (for organizations billing up to $100K/month) and a custom Enterprise tier, with an annual commitment discount option. Distribution is primarily direct enterprise field sales anchored on a 'Book a Demo' CTA, supplemented by a free-trial self-serve channel for mid-market prospects. The company is privately held under Digital Auxilius, headquartered at 28260 Franklin Rd, Southfield, Michigan, and reports 100+ trials managed and 340+ sites onboarded. Leadership includes Founder and CEO Dr. Mazhar Jaffry, Chief Product Officer Khizar Jaffry, and Director Dr. Ashfaq Ahmed Mian.

Note on source material: the firmographics header describes Syncora Holdings as a Bermuda-domiciled, NYSE-listed (SCA) monoline financial guarantee insurer founded in 2006, whereas all other source blocks and the scraped website describe a US-based private clinical trial SaaS company. This analysis is grounded in the latter body of evidence, which is first-party and internally consistent.

Syncora Holdings firmographics

Firmographics
Name
Syncora Holdings
Legal name
Syncora
Website
https://syncora.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
1–10 employees
Short description
Syncora is a US-based clinical trial SaaS platform, operated under Digital Auxilius, that helps research sites, sponsors, and CROs manage study startup, site activation, document control, and regulatory compliance through subscription-priced workflow modules.
Ownership category
akta.pro rank

Syncora Holdings industry classification

Industry
Product category
Clinical Trial Management Software
NAICS
Software Publishers (513210), Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro primary industry
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)
akta.pro secondary industry
Clinical Trial Site Operations & Study Coordination (HLAGACAE)

Keywords

  • Clinical trial software
  • Site startup management
  • Clinical research platform
  • Regulatory compliance software
  • Clinical study management

Where Syncora Holdings is headquartered

Location

Headquarters

HQ city
Hamilton
HQ country
Bermuda

Offices1 record

Markets served

Syncora Holdings business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Subscription (Teams Plan): Monthly subscription at $499/month for Teams tier with access to Site Startup, Study Startup, Dashboard Analytics, and Lead Management features. Billed monthly with annual commitment.
  2. Enterprise Pricing: Custom enterprise pricing for complex clinical research needs with scalable, secure, and intelligent solutions. Includes multi-site trial management, enterprise-level security, customizable workflows, and advanced analytics.
  3. Annual Subscription Discount: $4800/year annual commitment option, offering savings compared to monthly billing

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyTeams plan at $499/month for up to $100K billing/month with Site Startup, Study Startup, Dashboard Analytics, and Lead Management
SubscriptionAnnualEnterprise plan with custom pricing for complex clinical research needs
SubscriptionAnnualAnnual commitment option at $4800/year

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

Syncora Holdings product offering

Product offering

Core offering

Syncora provides a cloud-based SaaS platform that streamlines clinical trial study startup activities, including site selection, site activation, document management, regulatory compliance, investigator coordination, and multi-stakeholder collaboration. The platform is sold to pharmaceutical sponsors, contract research organizations (CROs), and clinical research sites on subscription-based Teams and Enterprise pricing plans.

Product overview

Syncora is a clinical study startup management platform delivered as a unified SaaS/hybrid solution. The core Syncora Platform serves as the central hub, integrated with modules for Site Startup, Lead Management, Study Startup, File Manager, User Management, Site Tours, Event Scheduler, and Investigator Management. Additional features include Networks for vendor coordination, Virtual Tour for site visualization, 21 CFR Part 11 compliance tools, and PSV-SIV Scheduler for visit coordination. The platform offers two pricing tiers: Teams ($499/month) and Enterprise (custom quote), supporting 100+ trials managed and 340+ sites onboarded.

Differentiator

Problem solved

Functional benefit

Products and services

  • Syncora Platform A cloud-based SaaS platform for clinical trial study startup management that streamlines site selection, site activation, document control, regulatory compliance, investigator coordination, lead management, and multi-stakeholder collaboration for pharmaceutical sponsors, CROs, and clinical research sites. Delivered as a subscription to pharmaceutical sponsors, CROs, and clinical research sites via Teams and Enterprise pricing plans.

Quantifiable outcome

  • 62.5% reduction in average site activation time (from 120 days to 45 days in oncology trial case study)
  • +7 more outcomes

Companies that use Syncora Holdings

Customer profile

Named customers10 records

Segments10 records

Ideal customer profiles3 records

Syncora Holdings technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature15 records

Syncora Holdings partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • SCRS (Site Choice and Retention Solutions)coreGTM or Marketing Partner · 1 September 2025Syncora was a Performance Sponsor of the SCRS Global Site Solutions Summit 2025 held in Orlando, Florida. The summit brings together sites, sponsors, CROs, and solution providers to tackle clinical trial challenges. Syncora participated at Booth #901 to engage with industry professionals about their study startup management solutions.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Syncora Holdings competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA's Orchestrated Clinical Trials suite includes site startup, CTMS, and site management offerings that compete for the same sponsor/CRO budget Syncora targets, with the added advantage of IQVIA's CRO services.
  • Veeva Systems: Veeva's Vault CTMS and Vault eTMF compete in clinical trial site and document management with a much broader life-sciences SaaS portfolio; the same enterprise buyers (sponsors, CROs) that Syncora targets are Veeva's core customers.
  • Oracle Clinical One: Oracle's Clinical One platform unifies CTMS, EDC, and eTMF for sponsors and CROs and competes for the same clinical operations workflow footprint that Syncora targets, especially around site startup and study conduct.
  • Medidata (Dassault Systèmes): Medidata's Rave platform spans CTMS, EDC, eCOA, and eTMF used by most large sponsors and CROs; it competes with Syncora for the clinical operations budget, particularly in site activation and study startup workflows.
  • Signant Health: Signant provides eCOA, eConsent, and clinical supply solutions that increasingly overlap with site startup and study conduct workflows targeted by Syncora, especially for sponsor-led studies.
  • WCG: WCG provides IRB, IBC, technology, and consulting services for clinical research sites and sponsors — overlapping Syncora's regulatory, site start-up, and compliance value proposition through a different operating model.

Emerging players

  • Castor: Castor offers a clinical trial data platform (EDC, ePRO, eConsent) with workflow tools aimed at sponsors, CROs, and sites — a comparable emerging SaaS peer competing for similar mid-market clinical research buyers.

Direct peers

  • Florence Healthcare: Florence's eBinders/eISF and Trial Site Engagement platform manage site regulatory documents, file workflows, and study startup tasks — a closely comparable offering to Syncora's File Manager and Site Startup modules.
  • RealTime Software Solutions: RealTime provides CTMS, eRegulatory, and site-management software widely used by independent research sites and site networks — directly competing with Syncora's site-side startup and compliance modules at similar price points.
  • Advarra: Advarra offers IRB, IBC, and clinical technology solutions (including its own CTMS-adjacent workflow tooling) for sites, sponsors, and CROs — directly overlapping Syncora's regulatory and study-startup workflow value proposition.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Syncora Holdings social profiles

Digital presence

Syncora Holdings financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Syncora Holdings leadership team

Management profile

Number of profiles

Profiles3 records

Syncora Holdings funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Syncora Holdings M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Syncora Holdings

What does Syncora Holdings do?

Syncora provides a cloud-based SaaS platform that streamlines clinical trial study startup activities, including site selection, site activation, document management, regulatory compliance, investigator coordination, and multi-stakeholder collaboration. The platform is sold to pharmaceutical sponsors, contract research organizations (CROs), and clinical research sites on subscription-based Teams and Enterprise pricing plans.

Is Syncora Holdings a public or private company?

Syncora Holdings is a private company. It is classified as corporate owned and is currently operating.

When was Syncora Holdings founded?

Syncora Holdings was founded in 2006. It employs 1 to 10 people.

Where is Syncora Holdings based?

Syncora Holdings is headquartered in Hamilton, Bermuda.

How does Syncora Holdings make money?

Three revenue lines are on record. SaaS Subscription (Teams Plan) is the primary driver. The others are enterprise Pricing and annual Subscription Discount.

Who are Syncora Holdings's main competitors?

Broad incumbents on record are IQVIA, Veeva Systems, Oracle Clinical One, Medidata (Dassault Systèmes), Signant Health and WCG. Castor is listed as an emerging player. Direct peers are Florence Healthcare, RealTime Software Solutions and Advarra.

Does Syncora Holdings have an API?

No public API is recorded for Syncora Holdings.

What industry is Syncora Holdings in?

Syncora Holdings's product category is Clinical Trial Management Software. Its primary akta.pro industry code is HLAGACAC, Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts), with a secondary code of HLAGACAE, Clinical Trial Site Operations & Study Coordination. Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireSyncora Holdings Ltd. Announces Meeting Date and Record Date for 2020 General Meeting of ShareholdersSyncora Holdings announced its 2020 Annual General Meeting will be held on March 26, 2021 via conference call. The record date for voting is February 12, 2021, and a proxy statement with dial-in instructions will be sent on that date.GlobeNewswireSyncora Holdings Ltd. Announces Shareholders Elect Directors at 2019 Annual General Meeting and Support Other Board RecommendationsSyncora Holdings shareholders elected Alan J. Carr and Frank C. Puleo to the Board at the 2019 Annual General Meeting. Shareholders also supported declassifying the Board, ratifying PricewaterhouseCoopers as independent accountants, and referring their remuneration to the Audit Committee.GlobeNewswireSyncora Holdings Ltd. Announces Changes to 2019 General Meeting of ShareholdersSyncora Holdings will hold its 2019 Annual General Meeting of Shareholders virtually on March 26, 2020, at 1:00 pm ET, due to the COVID-19 outbreak. Shareholders as of the February 20, 2020 record date are invited to attend via the company's virtual meeting website.GlobeNewswireSyncora Holdings Ltd. General Counsel and Secretary James W. Lundy, Jr. Steps Down Following Adoption of Company’s Plan of LiquidationSyncora Holdings announced that General Counsel and Secretary James W. Lundy, Jr. is stepping down following the adoption of a plan of liquidation. He played a key role in the sale of Syncora Guarantee to GoldenTree and oversaw litigation with recoveries exceeding $1.3 billion.GlobeNewswireSyncora Holdings Ltd. Announces Meeting Date and Record Date for Special General Meeting of Shareholders and Retirement of Michael P. Esposito, Jr. as Chairman after the MeetingSyncora Holdings will hold a special general meeting on January 28, 2020, with a record date of January 16, 2020. Michael P. Esposito, Jr. will resign as Chairman, and Dr. E. Grant Gibbons will become interim Chairman, reducing the board from 11 to 6 directors.GlobeNewswireSyncora Holdings Ltd. Announces Closing of SGI Sale and Timing of Distribution of Sale ProceedsSyncora Holdings closed the sale of its subsidiary SGI to Star Insurance, an entity organized by GoldenTree Asset Management. The company anticipates distributing net proceeds plus remaining liquid assets, estimated at about $415 million, after a plan of liquidation is approved by its board and shareholders in January 2020.GlobeNewswireSyncora Holdings Ltd. Announces Third Quarter 2019 Interim GAAP Consolidated Financial ResultsSyncora Holdings reported a net loss of $97.6 million for the nine months ended September 30, 2019, down from $19.3 million in 2018. The loss included a $132.7 million impairment on SGI and a $2.8 million write-down on Swap Financial. The company held a conference call on November 15 to discuss results.GlobeNewswireSyncora Holdings Ltd. Announces Second Quarter 2019 Interim GAAP Consolidated Financial ResultsSyncora Holdings reported net income of $37.4 million for the six months ended June 30, 2019, up from a $107.5 million loss in the same period of 2018. Net premiums earned fell to $1.8 million from $23.1 million, and adjusted book value per share was $7.86.GlobeNewswireSyncora Holdings Ltd. Announces Agreement to Sell Syncora Guarantee Inc. for $392.5 Million to Star Insurance Holdings LLC and Corporate Governance ChangeSyncora Holdings agreed to sell its subsidiary Syncora Guarantee Inc. to Star Insurance Holdings for $392.5 million in cash, subject to adjustment. The deal, expected to close by Q4 2019 or Q1 2020, leaves Syncora with $32 million in cash and non-core assets. The board also approved phasing out staggered board terms, effective at the 2019 AGM.GlobeNewswireSyncora Holdings Ltd. Announces First Quarter 2019 Interim GAAP Consolidated Financial ResultsSyncora Holdings reported Q1 2019 net income of $53.0 million, up from a $8.8 million loss in 2018. Net premiums earned fell to $0.6 million from $14.3 million, and adjusted book value per share rose to $7.54 from $6.76. The company will hold a conference call on May 14 to discuss results.